June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Deep Learning for Automated Detection of Neovascular Leakage and Vascular Nonperfusion in Diabetic Retinopathy Using Ultra-widefield Fluorescein Angiography
Author Affiliations & Notes
  • Peter Yu Cheng Zhao
    W K Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Nikhil Bommakanti
    W K Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Gina Yu
    W K Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Michael T Aaberg
    W K Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Tapan Patel
    W K Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Yannis Mantas Paulus
    W K Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Footnotes
    Commercial Relationships   Peter Zhao None; Nikhil Bommakanti None; Gina Yu None; Michael Aaberg None; Tapan Patel None; Yannis Paulus None
  • Footnotes
    Support  VitreoRetinal Surgery Foundation Research Award
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 236 – F0083. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peter Yu Cheng Zhao, Nikhil Bommakanti, Gina Yu, Michael T Aaberg, Tapan Patel, Yannis Mantas Paulus; Deep Learning for Automated Detection of Neovascular Leakage and Vascular Nonperfusion in Diabetic Retinopathy Using Ultra-widefield Fluorescein Angiography. Invest. Ophthalmol. Vis. Sci. 2022;63(7):236 – F0083.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neovascular leakage and vascular non-perfusion are angiographic features of diabetic retinopathy. The goal of this study was to determine whether these features could be accurately classified by a deep learning algorithm.

Methods : We used retrospective fluorescein angiogram images captured on the Optos ultra-widefield platform between January 2009 and May 2018. Images were randomly split into training (60%), validation (20%), and test (20%) sets. A ResNet-101 convolutional neural network that was pre-trained on ImageNet was trained on fluorescein angiogram images. The neural network was configured to output predictions on the presence of neovascular leakage and vascular non-perfusion. Predictions were compared to the ground truth labeled by masked, trained graders.

Results : 1452 images from 342 subjects were included. 60% of images were from female subjects, and 79% of images were from patients with type 2 diabetes mellitus. Mean hemoglobin A1c was 8.1% (SD=2.1%). Mean visual acuity was logMAR 0.35 (SD=0.30). Neovascular leakage was present in 21% of images, and non-perfusion greater than a pre-determined threshold (77.5 mm2) predictive of development of proliferative diabetic retinopathy was present in 42% of images. The mean total non-perfusion area was 80.8 mm2 (SD=63.3). The algorithm achieved an area under the curve (AUC) of 0.976 for neovascular leakage, and an AUC of 0.949 for detecting vascular non-perfusion. At operating points selected for high sensitivity, the algorithm achieved 97% sensitivity and 89% specificity for neovascular leakage, and 94% sensitivity and 79% specificity for non-perfusion. At operating points selected for high specificity, the algorithm achieved 75% sensitivity and 94% specificity for neovascular leakage, and 86% sensitivity and 86% specificity for non-perfusion.

Conclusions : A convolutional neural network was trained to recognize the presence of neovascular leakage and non-perfusion in ultra-widefield fluorescein angiography. Further research may help improve algorithm performance and better characterize the relationship between non-perfusion, neovascularization, and vision-threatening complications of diabetic retinopathy.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×